<DOC>
	<DOCNO>NCT00318058</DOCNO>
	<brief_summary>As influenza vaccine efficacy report low elderly subject compare healthy adult , probably result immunosenescence , desire devise way increase current vaccine efficacy target population . Adjuvants know boost immune response , thus represent one way increase efficacy current GlaxoSmithKline Fluarix™ influenza vaccine elderly subject . The purpose study evaluate immunogenicity reactogenicity revaccination adjuvanted GlaxoSmithKline influenza vaccine administer intramuscularly 1 year administration first dose vaccine . For immunogenicity safety evaluation , subject already receive Fluarix™ preceeding year receive dose commercial vaccine form control group trial .</brief_summary>
	<brief_title>Safety Study Adjuvanted Candidate Influenza Vaccine Prevent Influenza Disease Elderly Population</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>A male female age 65 year time revaccination ; previously receive adjuvanted candidate vaccine Fluarix clinical study organize preceeding year Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede administration study vaccine , plan use study period . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior administration study vaccine . History confirm influenza infection since year date previous vaccination . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination History hypersensitivity vaccine . History allergic disease reaction likely exacerbate component vaccine . Acute clinically significant pulmonary , cardiovascular , hepatic renal functional abnormality , determine physical examination laboratory screen test . Acute disease time enrolment . Administration immunoglobulins and/or blood product within three month precede administration study vaccine study .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>